Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Livio Criscuolo

Department of Clinical Medicine and Surgery, School of Medicine, University Federico II of Naples, Naples, Italy

Recent stories

  • Image 1 shows a normal spine and image 2 shows a spine affected by spondylitis

    TNFα-inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritisSubscription

    13 JAN 2017

    Spondyloarthropathy refers to a group of articular inflammatory diseases that share common genetic, clinical and radiological features in addition to their association with human leucocyte antigen (HLA)-B27 antigen. The aim of therapeutic management of patients with spondyloarthritis is to improve quality of life, control the symptoms of articular inflammation, prevent the structural damage of joints, and preserve the functional abilities, autonomy and social participation of patients.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.